BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27938671)

  • 1. Clinical and immunological assessment of therapeutic immunization with a subunit vaccine for recurrent ocular canine herpesvirus-1 infection in dogs.
    Ledbetter EC; Kim K; Dubovi EJ; Mohammed HO; Felippe MJB
    Vet Microbiol; 2016 Dec; 197():102-110. PubMed ID: 27938671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of topical ocular corticosteroid administration in dogs with experimentally induced latent canine herpesvirus-1 infection.
    Ledbetter EC; Kice NC; Matusow RB; Dubovi EJ; Kim SG
    Exp Eye Res; 2010 Jun; 90(6):711-7. PubMed ID: 20223234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of spontaneous canine herpesvirus-1 reactivation and ocular viral shedding in latently infected dogs and canine herpesvirus-1 reactivation and ocular viral shedding induced by topical administration of cyclosporine and systemic administration of corticosteroids.
    Ledbetter EC; da Silva EC; Kim SG; Dubovi EJ; Schwark WS
    Am J Vet Res; 2012 Jul; 73(7):1079-84. PubMed ID: 22738061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ocular surface strontium-90 beta radiotherapy in dogs latently infected with canine herpesvirus-1.
    Nicklin AM; McEntee MC; Ledbetter EC
    Vet Microbiol; 2014 Dec; 174(3-4):433-437. PubMed ID: 25465181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental reactivation of latent canine herpesvirus-1 and induction of recurrent ocular disease in adult dogs.
    Ledbetter EC; Kim SG; Dubovi EJ; Bicalho RC
    Vet Microbiol; 2009 Jul; 138(1-2):98-105. PubMed ID: 19345521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of topical ocular application of 1% trifluridine ophthalmic solution in dogs with experimentally induced recurrent ocular canine herpesvirus-1 infection.
    Spertus CB; Mohammed HO; Ledbetter EC
    Am J Vet Res; 2016 Oct; 77(10):1140-7. PubMed ID: 27668586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclophosphamide myelosuppression in adult dogs with latent canine herpesvirus-1 infection.
    Mundy P; da Silva EC; Ledbetter EC
    Vet Microbiol; 2012 Sep; 159(1-2):230-5. PubMed ID: 22480774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of topical ophthalmic ganciclovir gel for the treatment of dogs with experimentally induced ocular canine herpesvirus-1 infection.
    Ledbetter EC; Nicklin AM; Spertus CB; Pennington MR; Van de Walle GR; Mohammed HO
    Am J Vet Res; 2018 Jul; 79(7):762-769. PubMed ID: 29943639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine herpesvirus-1 ocular diseases of mature dogs.
    Ledbetter EC
    N Z Vet J; 2013 Jul; 61(4):193-201. PubMed ID: 23438442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental primary ocular canine herpesvirus-1 infection in adult dogs.
    Ledbetter EC; Dubovi EJ; Kim SG; Maggs DJ; Bicalho RC
    Am J Vet Res; 2009 Apr; 70(4):513-21. PubMed ID: 19335108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outbreak of ocular disease associated with naturally-acquired canine herpesvirus-1 infection in a closed domestic dog colony.
    Ledbetter EC; Kim SG; Dubovi EJ
    Vet Ophthalmol; 2009; 12(4):242-7. PubMed ID: 19604340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated canine herpesvirus (CHV) reactivation in dogs by an immunosuppressive drug.
    Okuda Y; Hashimoto A; Yamaguchi T; Fukushi H; Mori S; Tani M; Hirai K; Carmichael L
    Cornell Vet; 1993 Oct; 83(4):291-302. PubMed ID: 8306652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro and In Vivo Evaluation of Cidofovir as a Topical Ophthalmic Antiviral for Ocular Canine Herpesvirus-1 Infections in Dogs.
    Ledbetter EC; Spertus CB; Pennington MR; Van de Walle GR; Judd BE; Mohammed HO
    J Ocul Pharmacol Ther; 2015 Dec; 31(10):642-9. PubMed ID: 26418618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive ocular sampling for the detection of subclinical canine herpesvirus-1 shedding in dogs with experimentally-induced latent infection.
    Ledbetter EC; Spertus CB; Diel DG; Dubovi EJ
    Vet Microbiol; 2021 Mar; 254():109001. PubMed ID: 33540209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canid herpesvirus 1 (CHV-1)-related disease in older puppies and CHV-1 shedding in the vagina of adult pregnant dogs.
    Kapil S
    J Vet Diagn Invest; 2015 Nov; 27(6):758-61. PubMed ID: 26450840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine reproductive, respiratory, and ocular diseases due to canine herpesvirus.
    Evermann JF; Ledbetter EC; Maes RK
    Vet Clin North Am Small Anim Pract; 2011 Nov; 41(6):1097-120. PubMed ID: 22041206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of canine herpesvirus-1 in Turkish dog population.
    Yeşilbağ K; Yalçın E; Tuncer P; Yılmaz Z
    Res Vet Sci; 2012 Feb; 92(1):36-9. PubMed ID: 21075406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid treatment does not reactivate canine herpesvirus in red foxes.
    Reubel GH; Pekin J; Wright J; Venables D; French N
    J Wildl Dis; 2004 Apr; 40(2):238-48. PubMed ID: 15362823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus reactivation in bitches with a medical history of herpesvirus infection.
    Okuda Y; Ishida K; Hashimoto A; Yamaguchi T; Fukushi H; Hirai K; Carmichael LE
    Am J Vet Res; 1993 Apr; 54(4):551-4. PubMed ID: 8387252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suitability of canine herpesvirus as a vector for oral bait vaccination of foxes.
    Reubel GH; Wright J; Pekin J; French N; Strive T
    Vet Microbiol; 2006 May; 114(3-4):225-39. PubMed ID: 16417978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.